- Quality Improvement Programme
- Lipid QI Programme
Lipid Quality Improvement (QI) Programme
This programme has been solely funded by Novartis. Novartis were not involved in the development of the programme, content, selection of speakers or their arrangements. All content has been independently developed by PCCS.
This toolkit comprises a number of educational resources and is designed to support primary healthcare teams to enhance the quality of care delivered to patients with hypercholesterolaemia. It focuses on lipid management in primary and secondary prevention of CVD.
The programme comprises of four modules, that cover:
These modules were filmed in November 2023, which was prior to the publication of the updated NICE guideline NG238. As a result, throughout the videos reference is made to NICE CG181.
Introduction to the Lipids QI programme: